Researchers in Eswatini, in collaboration with an international consortium, have made a significant breakthrough in tuberculosis (TB) diagnostics. Using targeted genome sequencing, they detected drug
Researchers at the German Center for Infection Research (DZIF) have developed a promising single-dose malaria treatment that could help address growing drug resistance and simplify treatment for
On June 12, 2026, the Parliamentary Group against Antimicrobial Resistance (PKAMR) held a discussion under the title "High-tech agenda for antibiotics—strategic directions for innovation and security
Following infection, the Ebola virus can survive unnoticed in the human body for months or even years, hiding in areas with little immune surveillance like the central nervous system. The danger is
Qubigen, a company specializing in AI-driven drug discovery, recently announced the launch of a new collaborative project focused on the decentralized (federated) AI-driven design of antiviral
An international research team led by scientists from Heidelberg University’s Faculty of Medicine and the University of California, San Francisco (USA), has investigated a new method for diagnosing
The European Vaccines Hub (EVH) for Pandemic Readiness convened its annual consortium meeting at the Old University of the Marburg University, in Marburg, Germany, from May 19 to 21, 2026. The EVH is
With the FDA approval of Hepcludex (bulevirtide), a therapy for chronic hepatitis D developed at the Heidelberg Faculty of Medicine at Heidelberg University, Heidelberg University Hospital, and the
Although the infectious disease Lassa fever can be fatal, there is a lack of treatment options with proven efficacy. Researchers at the Bernhard Nocht Institute for Tropical Medicine (BNITM) and the
The World Health Organization (WHO) has declared the current Ebola outbreak in the Democratic Republic of the Congo (DR Congo) and Uganda a public health emergency of international concern. The
